Literature DB >> 30922751

Changes in vascular and inflammatory biomarkers after exercise rehabilitation in patients with symptomatic peripheral artery disease.

Andrew W Gardner1, Donald E Parker2, Polly S Montgomery3.   

Abstract

OBJECTIVE: Home-based exercise is an alternative exercise mode to a structured supervised program to improve symptoms in patients with peripheral artery disease (PAD), but little is known about whether the slow-paced and less intense home program also elicits changes in vascular and inflammatory biomarkers. In an exploratory analysis from a randomized controlled trial, we compared changes in vascular and inflammatory biomarkers in patients with symptomatic PAD (typical and atypical of claudication) after home-based exercise and supervised exercise programs and in an attention-control group.
METHODS: A total of 114 patients were randomized into one of the three groups (n = 38 per group). Two groups performed exercise interventions, consisting of home-based and supervised programs of intermittent walking to mild to moderate claudication pain for 12 weeks; a third group performed light resistance training as a nonwalking attention-control group. Before and after intervention, patients were characterized on treadmill performance and endothelial effects of circulating factors present in sera by a cell culture-based bioassay on primary human arterial endothelial cells, and they were further evaluated on circulating vascular and inflammatory biomarkers.
RESULTS: Treadmill peak walking time increased (P = .008) in the two exercise groups but not in the control group (P > .05). Cultured endothelial cell apoptosis decreased after home-based exercise (P < .001) and supervised exercise (P = .007), and the change in the exercise groups combined was different from that in the control group (P = .005). For circulating biomarkers, increases were found in hydroxyl radical antioxidant capacity (P = .003) and vascular endothelial growth factor A (P = .037), and decreases were observed in E-selectin (P = .007) and blood glucose concentration (P = .012) after home-based exercise only. The changes in hydroxyl radical antioxidant capacity (P = .005), vascular endothelial growth factor A (P = .008), and E-selectin (P = .034) in the exercise groups combined were different from those in the control group.
CONCLUSIONS: This exploratory analysis found that both home-based and supervised exercise programs are efficacious to decrease cultured endothelial cell apoptosis in patients with symptomatic PAD. Furthermore, a monitored home-based exercise program elicits additional vascular benefits by improving circulating markers of endogenous antioxidant capacity, angiogenesis, endothelium-derived inflammation, and blood glucose concentration in patients with symptomatic PAD. The novel clinical significance is that important trends were found in this exploratory analysis that a contemporary home-based exercise program and a traditional supervised exercise program may favorably improve vascular and inflammatory biomarkers in addition to the well-described ambulatory improvements in symptomatic patients with PAD.
Copyright © 2019 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Antioxidant capacity; Claudication; Endothelial cell apoptosis; Exercise; Inflammation

Mesh:

Substances:

Year:  2019        PMID: 30922751      PMCID: PMC6756934          DOI: 10.1016/j.jvs.2018.12.056

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  40 in total

1.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

Authors:  L Norgren; W R Hiatt; J A Dormandy; M R Nehler; K A Harris; F G R Fowkes
Journal:  J Vasc Surg       Date:  2007-01       Impact factor: 4.268

2.  Acute impairment of the endothelial function by maximal treadmill exercise in patients with intermittent claudication, and its improvement after supervised physical training.

Authors:  G M Andreozzi; A Leone; R Laudani; G Deinite; R Martini
Journal:  Int Angiol       Date:  2007-03       Impact factor: 2.789

3.  Impaired exercise-induced blood volume in type 2 diabetes with or without peripheral arterial disease measured by continuous-wave near-infrared spectroscopy.

Authors:  Emile R Mohler; Gwen Lech; Gregory E Supple; Hao Wang; Britton Chance
Journal:  Diabetes Care       Date:  2006-08       Impact factor: 19.112

4.  Mortality over a period of 10 years in patients with peripheral arterial disease.

Authors:  M H Criqui; R D Langer; A Fronek; H S Feigelson; M R Klauber; T J McCann; D Browner
Journal:  N Engl J Med       Date:  1992-02-06       Impact factor: 91.245

5.  D-dimer and inflammatory markers as predictors of functional decline in men and women with and without peripheral arterial disease.

Authors:  Mary M McDermott; Luigi Ferrucci; Kiang Liu; Michael H Criqui; Philip Greenland; David Green; Jack M Guralnik; Paul M Ridker; Lloyd M Taylor; Nader Rifai; Lu Tian; Jane Zheng; William H Pearce; Joseph R Schneider; Ed Vonesh
Journal:  J Am Geriatr Soc       Date:  2005-10       Impact factor: 5.562

6.  Effects of exercise rehabilitation on cardiovascular risk factors in older patients with peripheral arterial occlusive disease.

Authors:  A M Izquierdo-Porrera; A W Gardner; C C Powell; L I Katzel
Journal:  J Vasc Surg       Date:  2000-04       Impact factor: 4.268

7.  Association of obesity and metabolic syndrome with the severity and outcome of intermittent claudication.

Authors:  Jonathan Golledge; Anthony Leicht; Robert G Crowther; Paula Clancy; Warwick L Spinks; Francis Quigley
Journal:  J Vasc Surg       Date:  2006-11-21       Impact factor: 4.268

8.  Functional decline in patients with and without peripheral arterial disease: predictive value of annual changes in levels of C-reactive protein and D-dimer.

Authors:  Mary M McDermott; Kiang Liu; Jack M Guralnik; Luigi Ferrucci; David Green; Philip Greenland; Lu Tian; Michael H Criqui; Carol Lo; Nader Rifai; Paul M Ridker; Jane Zheng; William Pearce
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2006-04       Impact factor: 6.053

Review 9.  The myopathy of peripheral arterial occlusive disease: part 1. Functional and histomorphological changes and evidence for mitochondrial dysfunction.

Authors:  Iraklis I Pipinos; Andrew R Judge; Joshua T Selsby; Zhen Zhu; Stanley A Swanson; Aikaterini A Nella; Stephen L Dodd
Journal:  Vasc Endovascular Surg       Date:  2007 Dec-2008 Jan       Impact factor: 1.089

10.  D-dimer, inflammatory markers, and lower extremity functioning in patients with and without peripheral arterial disease.

Authors:  Mary McGrae McDermott; Philip Greenland; David Green; Jack M Guralnik; Michael H Criqui; Kiang Liu; Cheeling Chan; William H Pearce; Lloyd Taylor; Paul M Ridker; Joseph R Schneider; Gary Martin; Nader Rifai; Maureen Quann; Myriam Fornage
Journal:  Circulation       Date:  2003-06-16       Impact factor: 29.690

View more
  6 in total

1.  Examination of Changes in 6-minute Walk Distance and Related Factors in Patients with Perioperative Peripheral Arterial Disease.

Authors:  Takura Sasaki; Junichiroh Kaneko; Masahiro Ishizaka; Naoya Suzuki; Syuichiro Kimura
Journal:  Phys Ther Res       Date:  2021-09-29

Review 2.  Oxidative Stress in Peripheral Arterial Disease (PAD) Mechanism and Biomarkers.

Authors:  Salvatore Santo Signorelli; Salvatore Scuto; Elisa Marino; Anastasia Xourafa; Agostino Gaudio
Journal:  Antioxidants (Basel)       Date:  2019-09-02

Review 3.  Endothelial Dysfunction, Inflammation and Coronary Artery Disease: Potential Biomarkers and Promising Therapeutical Approaches.

Authors:  Diana Jhoseline Medina-Leyte; Oscar Zepeda-García; Mayra Domínguez-Pérez; Antonia González-Garrido; Teresa Villarreal-Molina; Leonor Jacobo-Albavera
Journal:  Int J Mol Sci       Date:  2021-04-08       Impact factor: 5.923

Review 4.  Circulating Biomarkers in Lower Extremity Artery Disease.

Authors:  Louise Ziegler; Ulf Hedin; Anders Gottsäter
Journal:  Eur Cardiol       Date:  2022-03-23

5.  Related factors associated with exercise behavior in patients with peripheral arterial disease.

Authors:  Takura Sasaki; Hiroshi Irie; Hiroki Harada; Naoya Suzuki; Syuichiro Kimura; Masahiro Ishizaka; Junichirou Kaneko; Tetsu Horaguchi
Journal:  J Phys Ther Sci       Date:  2022-02-23

Review 6.  Inflammatory and Prothrombotic Biomarkers, DNA Polymorphisms, MicroRNAs and Personalized Medicine for Patients with Peripheral Arterial Disease.

Authors:  Pavel Poredoš; Mišo Šabovič; Mojca Božič Mijovski; Jovana Nikolajević; Pier Luigi Antignani; Kosmas I Paraskevas; Dimitri P Mikhailidis; Aleš Blinc
Journal:  Int J Mol Sci       Date:  2022-10-10       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.